 Matthew Frank
Concepts (230)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microglia | 24 | 2021 | 218 | 5.950 |
Why?
| | Hippocampus | 29 | 2020 | 797 | 3.580 |
Why?
| | HMGB1 Protein | 8 | 2019 | 47 | 2.880 |
Why?
| | Glucocorticoids | 14 | 2019 | 553 | 2.800 |
Why?
| | Stress, Psychological | 14 | 2019 | 1066 | 2.540 |
Why?
| | Inflammasomes | 6 | 2020 | 115 | 2.430 |
Why?
| | Inflammation | 22 | 2023 | 2522 | 2.120 |
Why?
| | Lipopolysaccharides | 17 | 2023 | 861 | 2.030 |
Why?
| | Inflammation Mediators | 7 | 2018 | 509 | 2.000 |
Why?
| | Rats, Sprague-Dawley | 33 | 2022 | 2547 | 1.690 |
Why?
| | Rats | 44 | 2022 | 5516 | 1.680 |
Why?
| | Encephalitis | 6 | 2018 | 125 | 1.580 |
Why?
| | Brain | 9 | 2019 | 2693 | 1.470 |
Why?
| | Stress, Physiological | 4 | 2017 | 431 | 1.450 |
Why?
| | Receptors, Immunologic | 3 | 2019 | 205 | 1.300 |
Why?
| | Alarmins | 4 | 2018 | 24 | 1.300 |
Why?
| | Mycobacterium | 4 | 2023 | 104 | 1.120 |
Why?
| | Anti-Inflammatory Agents | 2 | 2018 | 461 | 1.030 |
Why?
| | Aging | 10 | 2018 | 1692 | 0.880 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 4 | 2012 | 254 | 0.860 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 7 | 2020 | 143 | 0.860 |
Why?
| | Animals | 52 | 2022 | 34126 | 0.830 |
Why?
| | Cytokines | 12 | 2018 | 1904 | 0.720 |
Why?
| | Limbic System | 1 | 2019 | 45 | 0.700 |
Why?
| | Cisterna Magna | 4 | 2013 | 8 | 0.690 |
Why?
| | Probiotics | 1 | 2018 | 51 | 0.650 |
Why?
| | Escherichia coli Infections | 4 | 2014 | 113 | 0.640 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2020 | 402 | 0.630 |
Why?
| | Neuroimmunomodulation | 6 | 2019 | 75 | 0.620 |
Why?
| | Memory Disorders | 5 | 2016 | 182 | 0.610 |
Why?
| | Interleukin-1beta | 10 | 2018 | 382 | 0.590 |
Why?
| | Antigens, CD | 2 | 2017 | 467 | 0.590 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2015 | 196 | 0.550 |
Why?
| | Central Nervous System | 2 | 2018 | 248 | 0.540 |
Why?
| | Down-Regulation | 1 | 2017 | 639 | 0.530 |
Why?
| | Methamphetamine | 1 | 2015 | 56 | 0.520 |
Why?
| | Carrier Proteins | 3 | 2015 | 739 | 0.510 |
Why?
| | Corticosterone | 7 | 2019 | 258 | 0.510 |
Why?
| | Male | 46 | 2022 | 60425 | 0.500 |
Why?
| | Peripheral Nervous System Diseases | 3 | 2010 | 121 | 0.480 |
Why?
| | Memory | 4 | 2018 | 271 | 0.450 |
Why?
| | Receptors, Interleukin-1 | 2 | 2012 | 229 | 0.440 |
Why?
| | Rats, Inbred F344 | 9 | 2018 | 250 | 0.420 |
Why?
| | Neuroglia | 3 | 2011 | 156 | 0.390 |
Why?
| | Mycobacteriaceae | 2 | 2020 | 20 | 0.380 |
Why?
| | Mifepristone | 4 | 2019 | 67 | 0.350 |
Why?
| | Cytoskeletal Proteins | 1 | 2009 | 148 | 0.350 |
Why?
| | Disease Susceptibility | 1 | 2011 | 345 | 0.340 |
Why?
| | Endotoxins | 1 | 2009 | 239 | 0.330 |
Why?
| | RNA, Messenger | 6 | 2020 | 2746 | 0.330 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 5 | 2012 | 1007 | 0.320 |
Why?
| | RNA, Antisense | 1 | 2007 | 24 | 0.310 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2007 | 89 | 0.300 |
Why?
| | Oxidative Stress | 1 | 2013 | 1194 | 0.290 |
Why?
| | Genes, MHC Class II | 1 | 2006 | 71 | 0.290 |
Why?
| | Centrifugation | 1 | 2005 | 32 | 0.280 |
Why?
| | Nerve Tissue Proteins | 1 | 2009 | 554 | 0.270 |
Why?
| | Histocompatibility Antigens | 1 | 2006 | 104 | 0.270 |
Why?
| | Signal Transduction | 2 | 2023 | 4810 | 0.270 |
Why?
| | Cell Separation | 1 | 2005 | 300 | 0.250 |
Why?
| | Spinal Cord | 6 | 2011 | 357 | 0.250 |
Why?
| | Interleukins | 1 | 2006 | 242 | 0.250 |
Why?
| | Receptors, Glucocorticoid | 3 | 2016 | 137 | 0.250 |
Why?
| | Immunity, Innate | 4 | 2015 | 757 | 0.250 |
Why?
| | Cell Culture Techniques | 1 | 2005 | 353 | 0.230 |
Why?
| | Substance-Related Disorders | 1 | 2011 | 958 | 0.220 |
Why?
| | Pathogen-Associated Molecular Pattern Molecules | 1 | 2021 | 8 | 0.220 |
Why?
| | Extinction, Psychological | 1 | 2022 | 81 | 0.210 |
Why?
| | Hot Temperature | 2 | 2022 | 356 | 0.200 |
Why?
| | Phosphate-Binding Proteins | 1 | 2020 | 5 | 0.200 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 102 | 0.200 |
Why?
| | Vaccination | 2 | 2020 | 1216 | 0.190 |
Why?
| | Toll-Like Receptor 2 | 2 | 2013 | 132 | 0.190 |
Why?
| | Immunization | 3 | 2018 | 416 | 0.190 |
Why?
| | Cerebrospinal Fluid Proteins | 1 | 2020 | 9 | 0.190 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2012 | 853 | 0.190 |
Why?
| | Interleukin-10 | 4 | 2014 | 304 | 0.190 |
Why?
| | Caspase 1 | 1 | 2020 | 143 | 0.180 |
Why?
| | Killer Cells, Natural | 1 | 2002 | 380 | 0.180 |
Why?
| | Hyperalgesia | 3 | 2011 | 110 | 0.180 |
Why?
| | HEK293 Cells | 1 | 2021 | 655 | 0.180 |
Why?
| | Interleukin-4 | 1 | 2020 | 204 | 0.170 |
Why?
| | Depressive Disorder | 1 | 2002 | 366 | 0.170 |
Why?
| | Macrophages | 4 | 2023 | 1328 | 0.170 |
Why?
| | Interleukin-6 | 4 | 2014 | 685 | 0.170 |
Why?
| | Rats, Inbred BN | 4 | 2012 | 55 | 0.170 |
Why?
| | Receptors, Pattern Recognition | 1 | 2018 | 10 | 0.170 |
Why?
| | Toll-Like Receptor 4 | 2 | 2013 | 340 | 0.170 |
Why?
| | Fear | 4 | 2022 | 310 | 0.160 |
Why?
| | Bacterial Vaccines | 1 | 2018 | 64 | 0.160 |
Why?
| | Circadian Rhythm | 3 | 2018 | 454 | 0.160 |
Why?
| | Genetic Therapy | 3 | 2010 | 261 | 0.160 |
Why?
| | Blood Proteins | 1 | 2020 | 251 | 0.160 |
Why?
| | Cognition | 2 | 2018 | 1080 | 0.160 |
Why?
| | Plasmids | 2 | 2010 | 380 | 0.150 |
Why?
| | Up-Regulation | 2 | 2013 | 882 | 0.150 |
Why?
| | Frontal Lobe | 1 | 2018 | 164 | 0.150 |
Why?
| | Lipid Metabolism | 1 | 2020 | 479 | 0.150 |
Why?
| | Neurogenic Inflammation | 1 | 2016 | 2 | 0.140 |
Why?
| | Amygdala | 1 | 2017 | 184 | 0.140 |
Why?
| | Time Factors | 6 | 2016 | 6885 | 0.140 |
Why?
| | Affect | 1 | 2018 | 264 | 0.140 |
Why?
| | Drug Synergism | 2 | 2013 | 339 | 0.140 |
Why?
| | Humans | 13 | 2023 | 121723 | 0.140 |
Why?
| | Adrenalectomy | 2 | 2014 | 80 | 0.140 |
Why?
| | Anxiety | 2 | 2020 | 873 | 0.130 |
Why?
| | Illness Behavior | 1 | 2014 | 11 | 0.130 |
Why?
| | Ventral Tegmental Area | 1 | 2015 | 46 | 0.130 |
Why?
| | Diet, High-Fat | 1 | 2016 | 242 | 0.130 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2013 | 343 | 0.130 |
Why?
| | Spleen | 2 | 2014 | 515 | 0.130 |
Why?
| | Behavior, Animal | 3 | 2012 | 506 | 0.120 |
Why?
| | Circadian Clocks | 1 | 2014 | 52 | 0.120 |
Why?
| | Laparotomy | 2 | 2011 | 113 | 0.120 |
Why?
| | Brain Mapping | 1 | 2018 | 594 | 0.120 |
Why?
| | Nucleus Accumbens | 1 | 2015 | 135 | 0.120 |
Why?
| | Prefrontal Cortex | 2 | 2015 | 310 | 0.120 |
Why?
| | Corpus Striatum | 1 | 2015 | 165 | 0.120 |
Why?
| | Proteomics | 1 | 2020 | 885 | 0.120 |
Why?
| | CD11b Antigen | 2 | 2010 | 58 | 0.120 |
Why?
| | Cognitive Dysfunction | 1 | 2018 | 316 | 0.120 |
Why?
| | Liver | 2 | 2014 | 1832 | 0.120 |
Why?
| | Injections, Spinal | 6 | 2010 | 101 | 0.120 |
Why?
| | Injections | 2 | 2013 | 166 | 0.110 |
Why?
| | Physical Conditioning, Animal | 2 | 2014 | 221 | 0.110 |
Why?
| | Sex Characteristics | 1 | 2018 | 699 | 0.110 |
Why?
| | Oxidation-Reduction | 1 | 2015 | 946 | 0.110 |
Why?
| | Pain | 4 | 2011 | 745 | 0.110 |
Why?
| | Receptor, Serotonin, 5-HT1A | 1 | 2011 | 40 | 0.100 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2011 | 41 | 0.100 |
Why?
| | DNA | 2 | 2010 | 1399 | 0.100 |
Why?
| | Interleukin-1 | 2 | 2007 | 984 | 0.100 |
Why?
| | HIV Envelope Protein gp120 | 2 | 2010 | 65 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2011 | 2046 | 0.100 |
Why?
| | Raphe Nuclei | 1 | 2011 | 118 | 0.100 |
Why?
| | Immune System | 1 | 2012 | 182 | 0.100 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2012 | 220 | 0.090 |
Why?
| | Fever | 1 | 2011 | 291 | 0.090 |
Why?
| | Genes, fos | 1 | 2009 | 37 | 0.090 |
Why?
| | Transcription Factors | 1 | 2018 | 1628 | 0.090 |
Why?
| | Microfilament Proteins | 1 | 2010 | 131 | 0.090 |
Why?
| | Hyperesthesia | 2 | 2006 | 7 | 0.090 |
Why?
| | Gene Transfer Techniques | 1 | 2010 | 147 | 0.090 |
Why?
| | Gene Expression Regulation | 2 | 2010 | 2499 | 0.090 |
Why?
| | Calcium-Binding Proteins | 1 | 2010 | 221 | 0.090 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2010 | 366 | 0.080 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2009 | 138 | 0.080 |
Why?
| | Neuronal Plasticity | 1 | 2009 | 229 | 0.080 |
Why?
| | Cognition Disorders | 1 | 2012 | 592 | 0.080 |
Why?
| | Foreign-Body Reaction | 1 | 2007 | 24 | 0.080 |
Why?
| | Hydrocortisone | 1 | 2009 | 333 | 0.070 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2014 | 1176 | 0.070 |
Why?
| | Pain Threshold | 1 | 2007 | 79 | 0.070 |
Why?
| | Catheterization | 1 | 2007 | 163 | 0.070 |
Why?
| | DNA, Complementary | 1 | 2006 | 274 | 0.070 |
Why?
| | Immunohistochemistry | 2 | 2010 | 1732 | 0.070 |
Why?
| | Cells, Cultured | 4 | 2018 | 4145 | 0.070 |
Why?
| | Disease Models, Animal | 2 | 2013 | 3798 | 0.070 |
Why?
| | Minocycline | 1 | 2005 | 29 | 0.070 |
Why?
| | Neuralgia | 1 | 2006 | 109 | 0.070 |
Why?
| | DNA Primers | 1 | 2006 | 546 | 0.070 |
Why?
| | Chemokines, CX3C | 1 | 2004 | 10 | 0.070 |
Why?
| | Morphine | 1 | 2004 | 141 | 0.060 |
Why?
| | Electroshock | 2 | 2013 | 154 | 0.050 |
Why?
| | Tissue Distribution | 2 | 2016 | 340 | 0.050 |
Why?
| | Postoperative Complications | 1 | 2012 | 2321 | 0.050 |
Why?
| | Age of Onset | 1 | 2002 | 479 | 0.050 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2006 | 862 | 0.050 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2002 | 572 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2006 | 1648 | 0.040 |
Why?
| | Flow Cytometry | 1 | 2002 | 1107 | 0.040 |
Why?
| | Escherichia coli | 2 | 2016 | 791 | 0.040 |
Why?
| | Optical Fibers | 1 | 2018 | 17 | 0.040 |
Why?
| | Pain Measurement | 2 | 2011 | 484 | 0.040 |
Why?
| | Vaccines, Inactivated | 1 | 2018 | 67 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2004 | 1076 | 0.040 |
Why?
| | Neurons | 1 | 2006 | 1370 | 0.040 |
Why?
| | Immunoassay | 1 | 2018 | 106 | 0.040 |
Why?
| | Host-Pathogen Interactions | 2 | 2011 | 315 | 0.040 |
Why?
| | Analgesics, Opioid | 1 | 2004 | 781 | 0.040 |
Why?
| | Memory, Long-Term | 1 | 2016 | 13 | 0.040 |
Why?
| | Lipids | 1 | 2020 | 607 | 0.040 |
Why?
| | Hormone Antagonists | 1 | 2016 | 43 | 0.040 |
Why?
| | Antibodies | 1 | 2018 | 400 | 0.030 |
Why?
| | Random Allocation | 1 | 2016 | 381 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2016 | 399 | 0.030 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2014 | 6 | 0.030 |
Why?
| | Alzheimer Disease | 1 | 2020 | 509 | 0.030 |
Why?
| | Phenotype | 1 | 2002 | 3079 | 0.030 |
Why?
| | Catalysis | 1 | 2014 | 296 | 0.030 |
Why?
| | Conditioning, Classical | 1 | 2014 | 100 | 0.030 |
Why?
| | Proteins | 1 | 2020 | 954 | 0.030 |
Why?
| | Injections, Intraventricular | 1 | 2012 | 84 | 0.030 |
Why?
| | Phosphatidylcholines | 1 | 2013 | 134 | 0.030 |
Why?
| | Cell Line | 1 | 2018 | 2814 | 0.030 |
Why?
| | Macrophages, Peritoneal | 1 | 2011 | 98 | 0.030 |
Why?
| | Physical Stimulation | 1 | 2011 | 96 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2018 | 2913 | 0.020 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2010 | 85 | 0.020 |
Why?
| | Polyglycolic Acid | 1 | 2010 | 40 | 0.020 |
Why?
| | Serotonin | 1 | 2011 | 330 | 0.020 |
Why?
| | Amnesia, Anterograde | 1 | 2008 | 4 | 0.020 |
Why?
| | Particle Size | 1 | 2010 | 348 | 0.020 |
Why?
| | Action Potentials | 1 | 2011 | 443 | 0.020 |
Why?
| | Exercise Test | 1 | 2011 | 617 | 0.020 |
Why?
| | Lactic Acid | 1 | 2010 | 295 | 0.020 |
Why?
| | Parietal Lobe | 1 | 2008 | 55 | 0.020 |
Why?
| | Hypothalamus | 1 | 2008 | 163 | 0.020 |
Why?
| | Cyclooxygenase 1 | 1 | 2007 | 22 | 0.020 |
Why?
| | Microinjections | 1 | 2006 | 85 | 0.020 |
Why?
| | Ligation | 1 | 2006 | 81 | 0.020 |
Why?
| | Sciatic Nerve | 1 | 2006 | 57 | 0.020 |
Why?
| | Cyclooxygenase 2 | 1 | 2007 | 176 | 0.020 |
Why?
| | Nanoparticles | 1 | 2010 | 327 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2010 | 739 | 0.020 |
Why?
| | Stress, Mechanical | 1 | 2007 | 426 | 0.020 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2004 | 14 | 0.020 |
Why?
| | Receptors, HIV | 1 | 2004 | 23 | 0.020 |
Why?
| | Chemokine CX3CL1 | 1 | 2004 | 17 | 0.020 |
Why?
| | Receptors, Cytokine | 1 | 2004 | 33 | 0.020 |
Why?
| | Nitric Oxide | 1 | 2010 | 868 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2006 | 770 | 0.020 |
Why?
| | Neuroprotective Agents | 1 | 2005 | 116 | 0.020 |
Why?
| | Drug Tolerance | 1 | 2004 | 133 | 0.020 |
Why?
| | Sialoglycoproteins | 1 | 2004 | 162 | 0.020 |
Why?
| | Female | 2 | 2018 | 63833 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2007 | 1383 | 0.010 |
Why?
| | Middle Aged | 1 | 2002 | 28928 | 0.010 |
Why?
| | Pain Management | 1 | 2004 | 303 | 0.010 |
Why?
| | Adult | 1 | 2002 | 32638 | 0.010 |
Why?
|
|
Frank's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|